CD38 and neoplasm: Consistent with these findings, analysis of the transferred Tregs population revealed a substantial reduction in the frequency of CD38−/− iTregs at the tumor site compared to that of WT iTregs, while their frequencies in the spleen and DLN remained comparable (Fig. 6B).